SCHEMBL24601217

SCHEMBL24601217

CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4ccccc4)nc(-c4cc(F)cc(F)c4)nc32)[C@H](O)[C@@H]1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.73
ADORA2A P29274 7/20 0.73
ADORA1 P30542 7/20 0.73
ADORA2B P29275 6/20 0.73
MAPK1 P28482 5/20 0.63
MAPT P10636 3/20 0.63
TP53 P04637 2/20 0.63
HTR2C P28335 2/20 0.63
HTR2B P41595 2/20 0.63
ABCG2 Q9UNQ0 2/20 0.63
CYP1A2 P05177 2/20 0.63
PPARG P37231 1/20 0.63
PPARD Q03181 1/20 0.63
CYP3A4 P08684 3/20 0.62
LMNA P02545 2/20 0.62
BLM P54132 2/20 0.62
PMP22 Q01453 2/20 0.62
CYP2D6 P10635 2/20 0.62
PKM P14618 2/20 0.62
TSHR P16473 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29073716 1.00 ADORA3 (0.73) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL29073718 1.00 ADORA3 (0.73) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL29073587 0.95 ADORA3 (0.72) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL29762180 0.95 ADORA3 (0.72) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL24600668 0.95 ADORA3 (0.72) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL29073585 0.95 ADORA3 (0.72) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL24600877 0.94 ADORA3 (0.75) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL29073614 0.94 ADORA3 (0.75) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL29073616 0.94 ADORA3 (0.75) ADORA3ADORA2AADORA1ADORA2BMAPK1
SCHEMBL24601385 0.93 ADORA3 (0.69) ADORA3ADORA2AADORA1ADORA2BMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116975-A1 ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD. (CN) 2024-04-11 US claimed
EP-4273153-A1 ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF Zhejiang Vimgreen Pharmaceuticals, Ltd (CN) 2023-11-08 EP claimed
CN-116783196-A A3 adenosine receptor agonists, methods of making and uses thereof 浙江春禾医药科技有限公司 2023-09-19 CN claimed
WO-2022143740-A1 ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF 浙江春禾医药科技有限公司 2022-07-07 WO claimed
US-20240116975-A1 ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF ZHEJIANG VIMGREEN PHARMACEUTICALS, LTD. (CN) 2024-04-11 US disclosed
EP-4273153-A1 ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF Zhejiang Vimgreen Pharmaceuticals, Ltd (CN) 2023-11-08 EP disclosed
WO-2022143740-A1 ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF 浙江春禾医药科技有限公司 2022-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116975-A1 ADENOSINE A3 RECEPTOR AGONISTS, PREPARATION METHODS AND USES THEREOF ADORA3, ADORA2A, ADORA2B ADORA3 1/4885ADORA2A 2/4885ADORA1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.